OSE Immunotherapeutics SA (EPA:OSE)
3.680
-0.126 (-3.31%)
At close: Mar 13, 2026
Revenue by Segment
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Source: S&P Global Market Intelligence.